1. Medtech Insight
  2. >>Policy & Regulation
  3. >>Regulation

FDA Focuses On Weeding Out Deficient PMAs

A draft guidance document designates “acceptance” criteria that when not met by a PMA will allow a reviewer to send the submission back to the sponsor more quickly.

FDA issued a draft guidance document July 30 intended to establish a quicker mechanism for reviewers to weed out certain deficient device pre-market approval applications, with the aim of focusing the agency’s limited review resources on applications that meet at least bare-minimum requirements for completion and data validity.

The draft guidelines, “Acceptance and Filing Review for Pre-Market Approval Applications,” update FDA’s 2003 PMA filing guidance. The...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Regulation

As Medtech Tariffs Loom, AdvaMed Responds With Its Own Plan Emphasizing ‘Reciprocal’ Free Trade

 
• By Brian Bossetta

The US Department of Commerce’s investigation into the national security impact of importing various medical equipment could lead to tariffs on many products. Device industry responds by emphasizing the robustness of domestic production, but also the rigidity of supply and reimbursement agreements.

Persistence Pays Off: New International Clinical Evaluation Standard Is Finally On Horizon

 
• By Amanda Maxwell

Clinical evaluation and standards expert Danielle Giroud celebrates progress on the document and looks at what it means internationally and for the EU.

German Medtechs Choking Under EU Compliance And Reporting Obligations Tout Mutual Recognition

 
• By Ashley Yeo

Industry survey points to ongoing low revenues rise and weaker profit levels for half of BVMed industry association members in 2025, as German manufacturers raise stakes on global harmonization.

Fixing The Fractures: New Aspirations For EU Medtech Regulatory Progress

 
• By Amanda Maxwell

A pioneering initiative, Edvance MedTech, is being launched by leading experts in medical technology regulation which aims get to the heart of what is needed to improve the way EU rules are not only applied but also decided.

More from Policy & Regulation

German Medtechs Choking Under EU Compliance And Reporting Obligations Tout Mutual Recognition

 
• By Ashley Yeo

Industry survey points to ongoing low revenues rise and weaker profit levels for half of BVMed industry association members in 2025, as German manufacturers raise stakes on global harmonization.

Fixing The Fractures: New Aspirations For EU Medtech Regulatory Progress

 
• By Amanda Maxwell

A pioneering initiative, Edvance MedTech, is being launched by leading experts in medical technology regulation which aims get to the heart of what is needed to improve the way EU rules are not only applied but also decided.

MedTech Innovator Winner Armor Medical Hopes To Reduce 90% Of Preventable Maternal Deaths

 
• By Marion Webb

Armor Medical’s wrist-worn wearable detected postpartum hemorrhage five times earlier than standard care in earlier studies. After surviving near-fatal hemorrhage herself, co-founder/CEO Kelsey Mayo aims to bring the device to market in 2028.